How to Buy Monopar Therapeutics Stock
Monopar Therapeutics
Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.
Monopar Therapeutics stock last closed at $102.05, up 16.2% from the previous day, and has increased 1,793.32% in one year. It has overperformed other stocks in the Biotechnology industry by 18.2 percentage points. Monopar Therapeutics stock is currently +2,167.78% from its 52-week low of $4.50, and -2.81% from its 52-week high of $105.00.
At the moment, there are 6.17M MNPR shares outstanding. The market capitalization of MNPR is $629.64M. In the past 24 hours, 89,000 MNPR shares were traded.
How to Buy Monopar Therapeutics Stock
Wondering how to invest in Monopar Therapeutics stock? Here's how.
- Figure out where to buy Monopar Therapeutics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you choose where to buy Monopar Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Pick your payment method and add your info.
- Analyze Monopar Therapeutics stock: The Monopar Therapeutics ticker symbol is MNPR. Is Monopar Therapeutics stock a good investment? Should you buy shares of MNPR? How do MNPR's underlying business fundamentals look? Do top analysts think Monopar Therapeutics is a good buy? Why has MNPR's stock price moved recently? (Hint: Our stock research tools can help you decide if MNPR is a good stock to buy).
- Execute your MNPR buy order: Decide if you will purchase MNPR shares at the current market price or use a limit order to buy MNPR shares at a specific price.
- Get the latest scoop on your MNPR position: Create a watchlist to keep track of your investment in Monopar Therapeutics shares.
Step 1: Figure out where to buy Monopar Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy MNPR stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal information so you are able to invest in MNPR today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create your new brokerage account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've filled out your info on app for stock, your next step is to transfer the money for your investment:
Check out the video below to see the process of transferring money into your brokerage account.
Step 4: Analyze Monopar Therapeutics stock
Once you have chosen the best place to buy Monopar Therapeutics stock, it's very important to analyze their stock before you invest, so you can wrap your head around the risk as well as the opportunity.
Monopar Therapeutics Numbers
MNPR Overview
WallStreetZen was created to help everyday investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on MNPR's stock page.
How is MNPR stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge MNPR's intrinsic value.
Using relative valuations methods:
- MNPR may be overvalued based on its P/B ratio of 12.06x, relative to Biotechnology industry P/B ratio of 4.94x
You can do more valuation analysis on MNPR's stock here.
A quick look at MNPR Financials
Passed Financial Due Diligence Checks:
- MNPR has a low debt to equity ratio of 0.03.
- Total MNPR debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the MNPR balance sheet.
- There are more short-term assets than short-term liabilities on the MNPR balance sheet.
- MNPR has $53.25M in cash and short term investments. This is sufficient to cover its annual cash burn of $9.81M.
- MNPR has cash burn of 9812605. It has sufficient cash and short-term investments to cover this for at least one year.
Do analysts think it's a good time to buy MNPR stock
Out of 9 sell side analysts who give forecasts on MNPR, the consensus analyst rating on MNPR is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent MNPR Analyst Upgrades/Downgrades
Jeet Mukherjee, a top 32% analyst from BTIG maintains MNPR with a strong buy rating and raises their MNPR price target from $87.00 to $104.00, on Sep 25, 2025.
Keay Nakae, a top 4% analyst from Chardan Capital maintains MNPR with a strong buy rating and raises their MNPR price target from $60.00 to $85.00, on Sep 25, 2025.
Chardan Capital's Keay Nakae raised their price target on Monopar Therapeutics (NASDAQ: MNPR) by 41.7% from $60 to $85 on 2025/09/25. The analyst maintained their Strong Buy rating on the stock.
On 2025/09/23, Monopar Therapeutics announced that the Journal of Hepatology had published a peer-reviewed Letter to the Editor.
The letter reports that recent evidence shows that copper balance in Wilson disease patients is quickly improved by ALXN1840, Nakae told readers.
Chad Messer, a bottom 2% analyst from Lake Street initiates coverage on MNPR with a strong buy rating and announces their MNPR price target of $106.00, on Sep 23, 2025.
Kristen Kluska, a top 2% analyst from Cantor Fitzgerald reiterates MNPR with a strong buy rating and maintains their MNPR price target from $74.00 to $74.00, on Aug 27, 2025.
You can dig deeper into what analysts are forecasting on the Monopar Therapeutics stock forecast page.
MNPR Trading Indicators
What are MNPR insiders up to?
Over the past 12 months, insiders at MNPR have sold more shares than they have bought.
Andrew Cittadine, Chief Operating Officer of MNPR, was the latest MNPR insider to sell. They sold $154,846.32 worth of MNPR stock on Sep 30, 2025.
Learn more about who owns MNPR stock here.
Does MNPR provide a stable income stream?
No, Monopar Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about MNPR
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your MNPR buy order
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount, use a limit order.
Click the Open button and eToro will execute the order.
If you need additional help buying stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your MNPR position
Now that you own some shares in MNPR, you'll want to keep up with your investment.
Create a watchlist to track your MNPR stock.
MNPR Feed
How to Buy Stock in Monopar Therapeutics
To summarize, here are the 6 steps you need to take to buy Monopar Therapeutics stock right now:
- Figure out where to buy Monopar Therapeutics stock
- Open a brokerage account
- Deposit money your investment account
- Analyze Monopar Therapeutics stock
- Execute your MNPR buy order
- Get the latest scoop on your MNPR position
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest news on your new investment in Monopar Therapeutics, create your watchlist below.
Other "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.